meglumine has been researched along with Paraganglioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guichard, JP; Herman, P; Huwart, L; Jourdan, G; Neves, F; Reizine, D; Vicaut, E | 1 |
Bloem, JL; Dillon, EH; Falke, TH; Pauwels, EK; Prins, HJ; van den Berg, R; van der Mey, AG; van Gils, AP | 1 |
1 trial(s) available for meglumine and Paraganglioma
Article | Year |
---|---|
MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
Topics: Adult; Aged; Contrast Media; Drug Combinations; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Paraganglioma; Pentetic Acid; ROC Curve; Sensitivity and Specificity | 1994 |
1 other study(ies) available for meglumine and Paraganglioma
Article | Year |
---|---|
Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Head and Neck Neoplasms; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Paraganglioma | 2008 |